Literature DB >> 18440067

Methylation status of SOCS1 and SOCS3 in BCR-ABL negative and JAK2V617F negative chronic myeloproliferative neoplasms.

Marta Fernández-Mercado, Virginia Cebrián, Begoña Euba, Marta García-Granero, María J Calasanz, Francisco J Novo, José L Vizmanos, Marina García-Delgado.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18440067     DOI： 10.1016/j.leukres.2008.03.014

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  7 in total

Review 1.  Therapy of myelofibrosis (excluding JAK2 inhibitors).

Authors:  Alessandro Rambaldi
Journal:  Int J Hematol       Date:  2010-02-24       Impact factor: 2.490

2.  Contrasting dynamic responses in vivo of the Bcl-xL and Bim erythropoietic survival pathways.

Authors:  Miroslav Koulnis; Ermelinda Porpiglia; P Alberto Porpiglia; Ying Liu; Kelly Hallstrom; Daniel Hidalgo; Merav Socolovsky
Journal:  Blood       Date:  2011-11-15       Impact factor: 22.113

Review 3.  Deactylase inhibition in myeloproliferative neoplasms.

Authors:  Sridurga Mithraprabhu; George Grigoriadis; Tiffany Khong; Andrew Spencer
Journal:  Invest New Drugs       Date:  2010-12-03       Impact factor: 3.850

4.  Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies.

Authors:  John Mascarenhas; Nitin Roper; Pratima Chaurasia; Ronald Hoffman
Journal:  Clin Epigenetics       Date:  2011-07-09       Impact factor: 6.551

5.  SOCS1 gene promoter methylation status is associated with in-stent restenosis after percutaneous coronary intervention.

Authors:  Liang Zhou; Ningfu Wang; Hong Li; Guoxin Tong; Jianmin Yang; Lei Lai; Hao Pan; Xianhua Ye; Jinyu Huang
Journal:  Oncotarget       Date:  2017-06-07

Review 6.  Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives.

Authors:  Alessandro M Vannucchi; Paola Guglielmelli; Alessandro Rambaldi; Costanza Bogani; Tiziano Barbui
Journal:  J Cell Mol Med       Date:  2009-06-11       Impact factor: 5.310

7.  Methylation profiling of SOCS1, SOCS2, SOCS3, CISH and SHP1 in Philadelphia-negative myeloproliferative neoplasm.

Authors:  Min Yue Zhang; Tsz Kin Fung; Fang Yuan Chen; Chor Sang Chim
Journal:  J Cell Mol Med       Date:  2013-10-16       Impact factor: 5.310
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.